The function of the neural cell adhesion molecule, NCAM, is modulated by the expression of the Nlinked polysialic acid (PSA) oligosaccharide chain, with PSA serving to decrease the adhesive potential of the protein backbone. In this study, we have generated clonal cells of the rat B104 and human SH-
Glucocorticoid induction of the α2,6 sialyltransferase enzyme in a mouse neural cell line
✍ Scribed by Christine M. Coughlan; Kieran C. Breen
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 272 KB
- Volume
- 51
- Category
- Article
- ISSN
- 0360-4012
No coin nor oath required. For personal study only.
✦ Synopsis
Combined sialyltransferase (ST) activities were induced in the HN9 hippocampal cell line following treatment with the synthetic glucocorticoid dexamethasone (dex) for 24 hr. Induction occurred in a dosedependent manner, with the maximum induction of a 2-fold increase over control enzyme levels occurring at a concentration of 10 -8 M dex. A minimum of 6 hr pretreatment with drug was required before significant induction could be detected and elevated enzyme levels persisted for up to 48 hr post-treatment. The induced form of the enzyme showed an increase in reaction maximum velocity (V max ) while showing no change in affinity (K m ) for the acceptor substrate asialofetuin. The ␣2,6 ST enzyme was demonstrated to be the primary enzyme induced and there was no change in expression of the ␣2,3 ST enzyme. Lectin blot analysis demonstrated an increase in the levels of the ␣2,6-linked cellular sialoglycoproteins and a parallel decrease in the ␣2,3 sialoglycoprotein levels.
📜 SIMILAR VOLUMES
The activity of -galactoside ␣2,6-sialyltransferase (ST6Gal.1), the enzyme responsible for the addition of sialic acid in ␣2,6-linkage to N-acetyllactosaminic (Gal1,4GlcNAc) units of glycoconjugates, is increased in the vast majority of colon cancer specimens, and a positive correlation with an in
A patient with malignant glioblastoma was treated with intratumoral infusions of the murine MAb425 (IgG 2A ) directed against the epidermal growth factor receptor. At the 10th infusion, the patient developed somnolence, fever and headache. The symptoms increased during the subsequent 48 hr but then